Gynostemma
Adaptogen
Overview
Gynostemma pentaphyllum, commonly called “jiao gu lan” or “southern ginseng,” is a climbing vine native to East Asia.
- Its leaves are rich in unique saponins called gypenosides.
- It is primarily used as a dietary supplement.
- It is aimed at supporting metabolic health, antioxidant defenses, and overall vitality.
Benefits
Clinical and pre‑clinical studies consistently report that Gynostemma supplementation can:
- Improve glucose homeostasis and insulin sensitivity: This is often reflected by modest reductions in fasting glucose (‑5 % to ‑10 % in randomized trials).
- Reduce serum LDL‑cholesterol and triglycerides: This is likely via up‑regulation of hepatic LDL‑receptor expression.
- Enhance antioxidant capacity: This decreases oxidative markers such as malondialdehyde and increases endogenous enzymes (SOD, catalase) in both human and rodent models.
- Support cardiovascular function: This includes modest reductions in systolic blood pressure (≈2–4 mm Hg) and improved endothelial flow‑mediated dilation in pilot studies.
- Exhibit neuroprotective effects in animal models: This includes improved memory performance and reduced neuroinflammation, suggesting potential cognitive benefits, although human data are still limited.
How It Works
The primary bioactive constituents are gypenosides, triterpenoid saponins structurally related to ginsenosides.
- AMPK Activation: They activate AMP‑activated protein kinase (AMPK) in muscle and liver, promoting glucose uptake, fatty‑acid oxidation, and mitochondrial biogenesis.
- PPAR Modulation: Gypenosides also bind to the nuclear receptor PPAR‑α/γ, modulating lipid metabolism and improving insulin signaling.
- eNOS Stimulation: In endothelial cells, they stimulate endothelial nitric-oxide synthase (eNOS) phosphorylation, enhancing nitric-oxide production and vasodilation.
- Antioxidant Effects: Antioxidant effects arise from direct free‑radical scavenging by the polyphenolic moiety and indirect up‑regulation of Nrf2, leading to increased expression of phase‑II detoxifying enzymes (HO‑1, NQO1).
- These combined actions underpin the observed metabolic, cardiovascular, and neuroprotective outcomes.
Dosage
Most human trials use:
- 250–500 mg of standardized Gynostemma extract (≥30 % gypenosides) taken 1–2 times daily with meals.
- Total daily intake typically ranges from 300 mg to 1 g.
- For glucose‑control protocols, 500 mg twice daily for 8–12 weeks is common.
- Athletes seeking endurance support often use 250 mg pre‑exercise.
- The extract should be standardized to ensure consistent gypenoside content; label claims of “100 mg gypenosides per capsule” are typical.
- Begin with the lower end to assess tolerance, then increase as needed.
- Individuals with severe hepatic or renal disease should consult a clinician before using doses >1 g/day.
Safety & Side Effects
Gynostemma is generally well‑tolerated.
- Mild adverse effects (≤5 % of users) include:
- Gastrointestinal upset
- Mild headache
- Dizziness
- Contraindications include:
- Pregnancy
- Lactation
- Individuals on anticoagulants (e.g., warfarin) because gypenosides may enhance platelet inhibition.
- Potential interactions exist with:
- Hypoglycemic agents (e.g., metformin, sulfonylureas) – additive glucose‑lowering may cause hypoglycemia.
- Caution is advised for patients on antihypertensive drugs; modest BP reductions may potentiate medication effects.
- Individuals with a history of hormone‑sensitive cancers should avoid long‑term use due to modest estrogenic activity observed in vitro.
Chemistry
Gypenosides are dammarane‑type triterpenoid saponins.
- A representative compound, Gypenoside A, has the molecular formula C₄₈H₈₀O₁₈.
- Its IUPAC name is (2R,3R,24R)-3‑hydroxy‑24‑(4‑hydroxy‑3‑methoxy‑phenyl)‑dammar-12‑ene‑3‑O‑β‑D‑glucopyranosyl‑(1→2)-β‑D‑glucopyranoside.
- These molecules possess a tetracyclic dammarane skeleton (four fused rings) with multiple hydroxyl groups and a glycosidic chain.
- This confers amphiphilic properties, enabling interaction with cell‑membrane receptors and the blood‑brain barrier.
- The high‑order glycosides (e.g., gypenoside II, III) differ in sugar composition (glucose, rhamnose, xylose).
- Their amphiphilic nature underlies both membrane‑stabilizing and signaling‑modulatory effects.
Sources & Quality
Gynostemma is cultivated primarily in China (Guangxi, Guangdong, Yunnan) and Vietnam.
- The leaves are harvested at 2–3 months of growth for maximal gypenoside content.
- Commercial extracts are obtained via:
- 70 % ethanol‑water extraction
- Followed by liquid‑chromatography purification to achieve the target ≥30 % gypenoside standardization.
- Some manufacturers use super‑critical CO₂ extraction to preserve heat‑labile compounds.
- Quality considerations include:
- Verification of gypenoside content by HPLC‑UV.
- Testing for heavy metals, pesticide residues, and microbial contamination.
- Certification of Good Manufacturing Practices (GMP).
- Look for:
- Third‑party testing
- Clear labeling of extraction method, standardization level, and batch‑specific certificates of analysis.
Where to Buy Gynostemma
Affiliate Disclosure: We earn a commission if you purchase through these links at no additional cost to you. This helps us maintain our research and provides you with the best supplement information.